Cite
HARVARD Citation
Kersten, M. et al. (2022). Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study. Journal of clinical oncology. 40 (1), pp. 40-51. [Online].